Freeze-dried Live Attenuated Hepatitis A Vaccine 冻干甲型肝炎减毒活疫苗 +
Live attenuated hepatitis A vaccine
甲型肝炎减毒活疫苗
- Markting Authorization Holder 上市许可持有人: Changsheng Biotechnology 长春生物
Registered Patent Information专利信息登记详情1
- Dosage/Administration 剂量和给药: 0.5 mL Injection | 注射剂
- Patent Number 相关专利号: ZL200810051441.9
- Claim No. 权利要求项编号: 1
- Patent Type 专利类型: Medical use 医药用途
- Expiration 保护期届满日2: 2028-11-17
Daratumumab 达雷妥尤单抗 +
CD38 antibody
CD38抗体
- Markting Authorization Holder 上市许可持有人: Genmab 根马布
- Dosage/Administration 剂量和给药: 1800 mg Injection | 注射剂
Registered Patent Information专利信息登记详情1
- Patent Number 相关专利号: ZL200680017915.7, ZL201710164800.0
- Claim No. 权利要求项编号: 1-4, 6, 8-10, 13, 29, 30, 34-36, 40, 41; 19, 20, 22, 25-27, 29, 30
- Patent Type 专利类型: Sequence of active biological ingredients; Medical use 生物制品活性成分的序列结构; 医药用途
- Expiration 保护期届满日2: 2029-10-27
Dupilumab 度普利尤单抗 +
IL-4 Receptor antibody
IL-4受体抗体
- Markting Authorization Holder 上市许可持有人: Regeneron Pharmaceuticals 再生元制药
- Dosage/Administration 剂量和给药: 200 mg Injection | 注射剂
Registered Patent Information专利信息登记详情1
- Patent Number 相关专利号: ZL200980143007.6, ZL201410018529.6
- Claim No. 权利要求项编号: 11-5, 13, 16; 1-8, 16
- Patent Type 专利类型: Sequence of active biological ingredients; Medical use 生物制品活性成分的序列结构; 医药用途
- Expiration 保护期届满日2: 2029-10-27
1 China has implemented a patent linkage system in the fourth amendments to its patent law, which became effective June 1, 2021 (Article 76 of the Patent Law of the People’s Republic of China (2020)). A patent registration platform has been set up for the Marketing Authorization Holder (MAH) to register certain drug product-related patent information. For biologics, patents may be registered include those directed to the active pharmaceutical ingredient (API) sequence/structure information and medical use.
2 Excluding any patent term adjustment or patent term extension. The fourth amendment to the Chinese patent law introduces the patent term adjustment (PTA) and patent term extension (PTE).